Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade

World Journal of Gastrointestinal Oncology

Volumn 9, Issue 9, 2017, Pages 354-362

  Grotz, Travis Edward ^a   Royal, Richard E ^a   Mansfield, Paul F ^a   Overman, Michael James ^a   Mann, Gary N ^a   Robinson, Kristen Ashlee ^a   Beaty, Karen A ^a   Rafeeq, Safiea ^a   Matamoros, Auerlio ^a   Taggart, Michelle W ^a   Fournier, Keith Francis ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Grade; Histology; Hyperthermic intraperitoneal chemotherapy; Outcomes; Prognostic; Pseudomyxoma peritonei

Indexed keywords

EID: 85041698802     PISSN: None     EISSN: 19485204     Source Type: Journal    
DOI: 10.4251/wjgo.v9.i9.354     Document Type: Article

References (18)

1. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109. cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 1995; 19: 1390-1408 [PMID: 7503361 DOI: 10.1097/00000478-199512000-00006]
2. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001; 92: 85-91 [PMID: 11443613 DOI: 10.1002/1097-0142(20010701)92]
3. Bruin SC, Verwaal VJ, Vincent A, van't Veer LJ, van Velthuysen ML. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Ann Surg Oncol 2010; 17: 2330-2340 [PMID: 20232161 DOI: 10.1245/s10434-010-0984-5]
4. Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B. Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg 2013; 79: 1171-1176 [PMID: 24165252]
5. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 2008; 98: 277-282 [PMID: 18726894 DOI: 10.1002/jso.21054]
6. Bradley RF, Stewart JH, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006; 30: 551-559 [PMID: 16699309 DOI: 10.1097/01.pas.0000202039.74837.7d]
7. Edge SB. American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer, 2010
8. Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, Taflampas P, Chapman S, Moran BJ. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. Am J Surg Pathol 2016; 40: 14-26 [PMID: 26492181 DOI: 10.1097/PAS.0000000000000535]
9. Choe JH, Overman MJ, Fournier KF, Royal RE, Ohinata A, Rafeeq S, Beaty K, Phillips JK, Wolff RA, Mansfield PF, Eng C. Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms. Ann Surg Oncol 2015; 22: 2578-2584 [PMID: 25582740 DOI: 10.1245/s10434-014-4335-9]
10. Grotz TE, Mansfield PF, Royal RE, Mann GN, Rafeeq S, Beaty KA, Overman MJ, Fournier KF. Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma. Ann Surg Oncol 2016; 23: 2914-2919 [PMID: 27027310 DOI: 10.1245/s10434-016-5209-0]
11. Edge SB. American Joint Committee on Cancer., American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York: Springer, 2010
12. Aaltonen LA, Hamilton SR. World Health Organization, International Agency for Research on Cancer. Pathology and genetics of tumours of the digestive system. Lyon Oxford: IARC Press, 2000
13. Overman MJ, Fournier K, Hu CY, Eng C, Taggart M, Royal R, Mansfield P, Chang GJ. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Ann Surg 2013; 257: 1072-1078 [PMID: 23001080 DOI: 10.1097/SLA.0b013e318269d680]
14. Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Zhu B, Nikiforova M, Bartlett DL, Pai RK. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol 2014; 27: 1521-1539 [PMID: 24633196 DOI: 10.1038/modpathol.2014.37]
15. Sirintrapun SJ, Blackham AU, Russell G, Votanopoulos K, Stewart JH, Shen P, Levine EA, Geisinger KR, Bergman S. Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol 2014; 45: 1597-1604 [PMID: 24814804 DOI: 10.1016/j.humpath.2014.03.007]
16. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL. Early-and longterm outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012; 30: 2449-2456 [PMID: 22614976 DOI: 10.1200/JCO.2011.39.7166]
17. Asare EA, Compton CC, Hanna NN, Kosinski LA, Washington MK, Kakar S, Weiser MR, Overman MJ. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base. Cancer 2016; 122: 213-221 [PMID: 26506400 DOI: 10.1002/cncr.29744]
18. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007; 245: 104-109 [PMID: 17197972 DOI: 10.1097/01. sla.0000231705.40081.1a]